MedTrace Logo

Effectiveness of a Homecare Dentin Hypersensitivity Gel

NCT02128633 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2014-05-01

No results posted yet for this study

Summary

Aim: To evaluate the effectiveness of a desensitizing gel for topical and home use in the treatment of dentin hypersensitivity (DH) through a randomized clinical trial, double-blind, with three parallel treatment. Methods: 126 subjects were divided into three groups: placebo gel (PG), test gel (TG) (5% sodium fluoride, potassium oxalate 5%, strontium chloride 10%) and sodium fluoride gel (2% FG ). The measurement of DH was performed by a single examiner blinded by the visual analog scale (VAS) after tactile, thermal and osmotic stimuli in the Baseline, 7, 15 and 30 days.

Conditions

  • Dentin Sensitivity

Interventions

DRUG

placebo gel

Manipulated at Novaderme ®, Santa Maria, RS, Brazil.

DRUG

5% sodium fluoride, potassium oxalate 5%, strontium chloride 10%

Manipulated at Novaderme ®, Santa Maria, RS, Brazil.

DRUG

Fluoride neutral NaF gel 2 %

The product had similar appearance and viscosity than others.

Sponsors & Collaborators

  • Franciscan University Center

    collaborator OTHER

  • Universidade Federal de Santa Maria

    lead OTHER

Principal Investigators

  • Fabricio B Zanatta, pHD · Universidade Federal de Santa Maria

  • ALESSANDRA P GRELLMANN, DS · Universidade Federal de Santa Maria

  • ROBERTO C VIANNA SANTOS, pHD · Centro Universitário Franciscano

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2013-06-30
Completion
2014-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02128633 on ClinicalTrials.gov